1. Home
  2. VMI vs ERAS Comparison

VMI vs ERAS Comparison

Compare VMI & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valmont Industries Inc.

VMI

Valmont Industries Inc.

N/A

Current Price

$385.66

Market Cap

7.4B

Sector

Industrials

ML Signal

N/A

Logo Erasca Inc.

ERAS

Erasca Inc.

N/A

Current Price

$13.60

Market Cap

6.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VMI
ERAS
Founded
1946
2018
Country
United States
United States
Employees
10791
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
6.3B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
VMI
ERAS
Price
$385.66
$13.60
Analyst Decision
Strong Buy
Buy
Analyst Count
5
10
Target Price
★ $610.75
$25.10
AVG Volume (30 Days)
162.5K
★ 5.1M
Earning Date
10-20-2026
11-12-2026
Dividend Yield
★ 0.75%
N/A
EPS Growth
N/A
★ 36.23
EPS
★ 17.88
N/A
Revenue
★ $3,169,556,000.00
N/A
Revenue This Year
$6.09
N/A
Revenue Next Year
$7.43
N/A
P/E Ratio
$22.93
★ N/A
Revenue Growth
★ 14.52
N/A
52 Week Low
$379.28
$2.81
52 Week High
$585.71
$24.28

Technical Indicators

Market Signals
Indicator
VMI
ERAS
Relative Strength Index (RSI) 30.31 42.80
Support Level N/A $13.18
Resistance Level $487.35 $15.71
Average True Range (ATR) 13.46 1.31
MACD -0.86 -0.13
Stochastic Oscillator 2.31 14.12

Price Performance

Historical Comparison
VMI
ERAS

About VMI Valmont Industries Inc.

Valmont Industries Inc, along with its subsidiaries, operates as a manufacturer of products and services for infrastructure and agriculture markets. Its reportable segments are Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment, which includes the manufacturing and distribution of products and solutions to serve the infrastructure markets of utility, solar, lighting, transportation, and telecommunications, along with coatings services to protect metal products. The Agriculture segment provides irrigation equipment components, including aftermarket parts and tubular products, and technology solutions for precision agriculture. Geographically, it derives key revenue from the United States, followed by Australia, Brazil, and other regions.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

Share on Social Networks: